https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-11-11 / Radiother Oncol 2010 Dec;97(3):535-40
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-11-11 / Radiother Oncol 2010 Dec;97(3):535-402010-11-11 00:00:002010-11-11 00:00:00Durable palliation of breast cancer chest wall recurrence with radiation therapy, hyperthermia, and chemotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-11-11 / Int J Hyperthermia 2011;27(1):53-62
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-11-11 / Int J Hyperthermia 2011;27(1):53-622010-11-11 00:00:002019-02-15 09:17:22Hyperthermia enhances the effect of β-lapachone to cause γH2AX formations and cell death in human osteosarcoma cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-11-08 / Proc. Natl. Acad. Sci. U.S.A. 2010 Nov;107(47):20477-82
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-11-08 / Proc. Natl. Acad. Sci. U.S.A. 2010 Nov;107(47):20477-822010-11-08 00:00:002019-02-15 09:17:26NADPH oxidase-mediated reactive oxygen species production activates hypoxia-inducible factor-1 (HIF-1) via the ERK pathway after hyperthermia treatment
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-11-08 / Strahlenther Onkol 2010 Nov;186(11):587-99
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-11-08 / Strahlenther Onkol 2010 Nov;186(11):587-992010-11-08 00:00:002019-02-15 08:39:20Combination of ionising irradiation and hyperthermia activates programmed apoptotic and necrotic cell death pathways in human colorectal carcinoma cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-11-01 / Tumori 2010 Nov-Dec;96(6):902-10
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-11-01 / Tumori 2010 Nov-Dec;96(6):902-102010-11-01 00:00:002019-02-15 09:17:22The role of hyperthermia in the battle against cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-11-01 / Gan To Kagaku Ryoho 2010 Nov;37(12):2243-5
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-11-01 / Gan To Kagaku Ryoho 2010 Nov;37(12):2243-52010-11-01 00:00:002019-02-15 09:17:23[Multidisciplinary therapy for 984 cancer patients–hyperthermic immunotherapy]
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-11-01 / Singapore Med J 2010 Nov;51(11):e187-90
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-11-01 / Singapore Med J 2010 Nov;51(11):e187-902010-11-01 00:00:002010-11-01 00:00:00Palliation of recurrent myxofibrosarcoma with radiotherapy and hyperthermia
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-09-30 / Cancer 2011 Feb;117(3):510-6
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-09-30 / Cancer 2011 Feb;117(3):510-62010-09-30 00:00:002019-02-15 10:00:34Hyperthermia combined with radiation for the treatment of locally advanced prostate cancer: long-term results from Dana-Farber Cancer Institute study 94-153
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-09-21 / Int J Hyperthermia 2011;27(2):180-6
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-09-21 / Int J Hyperthermia 2011;27(2):180-62010-09-21 00:00:002019-02-15 09:17:26Intracavity hyperthermia in nasopharyngeal cancer: a phase III clinical study
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-09-21 / Int J Hyperthermia 2010;26(8):748-64
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-09-21 / Int J Hyperthermia 2010;26(8):748-642010-09-21 00:00:002019-02-15 10:00:35Measurement and mathematical modeling of thermally induced injury and heat shock protein expression kinetics in normal and cancerous prostate cells
